At baseline, after correcting for covariates, cg11251498 (IDO2) did not show a significant difference in DNA methylation levels when comparing SCD, MCI, and dementia patients (model 1, p = 0.58; model 2, p = 0.55). Here, IDO2 is linked to dementia.